Annual report pursuant to Section 13 and 15(d)

Provision for Income Taxes - Additional Information (Detail)

v3.24.1
Provision for Income Taxes - Additional Information (Detail)
$ in Thousands
1 Months Ended 12 Months Ended
Apr. 01, 2023
Mar. 31, 2023
Aug. 16, 2022
Jul. 31, 2021
Aug. 31, 2021
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Income Taxes Disclosure [Line Items]                
Operating loss carryforwards, limitations on use           Net federal operating loss carryforwards generated after January 1, 2018 may be carried forward indefinitely, subject to the 80% taxable income limitation on the utilization of the carryforwards.    
Research and development credit carry forward           $ 8,791 $ 6,617  
Foreign net loss carryforwards           $ 24,961    
Tax rate           4.94% (9.93%)  
Tax benefit relating to change in valuation allowance resulting from acquisition           $ 225    
Increase in income tax provision           3,159    
Accrued taxes           1,268    
Unrecognized tax benefits netted against its deferred tax assets within other assets           $ 6,873 $ 1,650 $ 1,111
Unrecognized tax benefits would impact effective tax rate if recognized           3.839    
Unrecognized tax benefits if recognized           $ 3,890    
Deferred tax asset for tax attribute carryforwards           $ 2,021    
Local tax rate on distribution           20.00%    
Corporate alternative minimum tax     15.00%          
Excise tax on net share repurchases     1.00%          
UK                
Income Taxes Disclosure [Line Items]                
Corporation tax rate 25.00% 19.00%            
Israeli [Member]                
Income Taxes Disclosure [Line Items]                
Tax rate       23.00% 12.00%      
Federal [Member]                
Income Taxes Disclosure [Line Items]                
Operating loss carry forward           $ 181,155    
Operating loss carry forwards expiration year           2036    
Research and development credit carry forward           $ 7,357    
Research and development credit expiration year           2036    
State [Member]                
Income Taxes Disclosure [Line Items]                
Operating loss carry forward           $ 127,005    
Operating loss carry forwards expiration year           2028    
Research and development credit carry forward           $ 4,415